Could cause temporary or reversible harm; serious harm is unlikely.
Sub-Potent Drug: Out of specification for assay at the 24 month interval.
| Brand name | LEVOTHYROXINE SODIUM |
| Generic name | LEVOTHYROXINE SODIUM |
| Active ingredient(s) | LEVOTHYROXINE SODIUM |
| Distributed by / for | Alvogen Inc, Pine Brook, NJ 07058 |
| NDC | 47781-654-90 |
| Full product label | Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc., Shenandoah, IA, 51601, Distributed by: Alvogen Inc, Pine Brook, NJ 07058, NDC 47781-654-90. |
| Recalling firm | Alvogen, Inc |
| Distribution | Nationwide and Puerto Rico. |
| Quantity | 21,276 bottles |
| Recall initiated | 2023-02-06 |
| Report date | 2023-03-08 |
| Recall completed | 2024-03-18 |
| Recall number | D-0353-2023 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Morristown NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗